Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
Biochemical Pharmacology|February 12, 2020
Biological evaluation of non-basic chalcone CYB-2 as a dual ABCG2/ABCB1 inhibitorChao-Yun Cai, Wei Zhang, Jing-Quan Wang, et al.
Acta Pharmaceutica Sinica. B|April 12, 2019
The epigallocatechin gallate derivative Y6 reverses drug resistance mediated by the ABCB1 transporter both in vitro and in vivoYan Wen, Ruiqiang Zhao, Pranav Gupta, et al.
Frontiers in Oncology|November 9, 2020
Sapitinib Reverses Anticancer Drug Resistance in Colon Cancer Cells Overexpressing the ABCB1 TransporterHai-Ling Gao, Pranav Gupta, Qingbin Cui, et al.
Molecular Therapy Oncolytics|July 17, 2020
A Small Molecule Inhibitor, OGP46, Is Effective against Imatinib-Resistant BCR-ABL Mutations via the BCR-ABL/JAK-STAT PathwayLiuya Wei, Yang Yang, Pranav Gupta, et al.
Oncotarget|October 31, 2015
A-803467, a tetrodotoxin-resistant sodium channel blocker, modulates ABCG2-mediated MDR in vitro and in vivoNagaraju Anreddy, Atish Patel, Yun-Kai Zhang, et al.
Frontiers in Genetics|October 26, 2020
Genetic Association of ACE2 rs2285666 Polymorphism With COVID-19 Spatial Distribution in IndiaAnshika Srivastava, Audditiya Bandopadhyay, Debashurti Das, et al.
European Journal of Medicinal Chemistry|July 15, 2019
Benzoyl indoles with metabolic stability as reversal agents for ABCG2-mediated multidrug resistanceChao-Yun Cai, Hong Zhai, Zi-Ning Lei, et al.
Pageof 15